Drug Development and Innovation Centre

Centre Governance & Board of Directors

Dr. Raimar Löbenberg, Ph.D.
Professor, Faculty of Pharmacy and Pharmaceutical Sciences
Director, Drug Development and Innovation Centre

Dr. Raimar Loebenberg's background  

 

 


Board of Directors
DDIC’s Board of Directors and the Industry Advisory Committee are closely involved in the review and oversight process contributing to the center's decision making and its interaction with industry.. The Board comprises of prominent leaders in the field of medicine and pharmaceutical sciences.

Dr. Ayman El-Kadi, Ph.D
Professor and Dean, Qatar University, College of Pharmacy

Dr. El-Kadi received his BSc in Pharmacy and MSc in Pharmacology from Tripoli and Benghazi University (Libya) in 1990 and 1994, respectively. Also, he is a registered pharmacist in Libya and Canada. In 1999 he received his PhD in Pharmacology from University of Montreal (Montreal, Quebec, Canada). Thereafter, he did postdoctoral training in Molecular Toxicology at the University of Western Ontario (London, Ontario, Canada). Dr. El-Kadi was a professor in the Faculty of Pharmacy and Pharmaceutical Sciences at the University of Alberta (Edmonton, Alberta, Canada) since 2001.  He was the Chair of Pharmaceutical Sciences Division (2005-2008), Director of Graduate Studies (2008-2009), and the Associate Dean for Research and Graduate Studies (2009-2013). 
Dr. El-Kadi’s research interests are in the areas of Pharmacology and Molecular and Environmental Toxicology. His research resulted in over 120 peer-reviewed papers in prestigious journals and similar number of abstracts and presentations. His research is supported by the Natural Sciences and Engineering Research Council (NSERC), Canadian Institute of Health Research (CIHR), Heart and Stroke Foundation of Canada, Canadian Foundation for Innovation (CFI) and several Biotech companies. He has supervised significant number of undergraduate, MSc, PhD students and postdoctoral fellows. He has served as editor, associate editor and member of the editorial board for a number of journals in the pharmaceutical sciences.

Dr. Richard N Fedorak, MD, FRCPC
Dean, Faculty of Medicine and Dentistry
Professor of Medicine, Division of Gastroenterology, University of Alberta
Director, Centre of Excellence for Gastrointestinal Inflammation and Immunity Research (CEGIIR) and Northern Alberta Clinical Trials and Research Centre (NACTRC)

Dr. Richard Fedorak received his medical degree in 1978 with First Class Honours from the University of Alberta. His postdoctoral training included an internship at the University of Western Ontario and residency training in General Internal Medicine at University of Toronto. His Gastroenterology Clinical and Research Fellowship training was carried out at the University of Chicago, Chicago and Columbia University, New York. In 1987, Dr. Fedorak returned to the University of Alberta as an AHFMR Clinical Investigator. A recipient of numerous awards, research fellowships and grants, Dr. Fedorak is a recognised expert in inflammatory bowel disease. He has an active basic gastrointestinal research laboratory in the area of mucosal immunology, inflammation, and membrane function and structure. In addition, he leads a large gastrointestinal disease clinical research group. Dr. Fedorak serves on multiple national and international scientific advisory boards. He has published over 400 peer-reviewed manuscripts and book chapters, produced two patents on colonic-specific drug delivery and has lectured around the world. He has multiple grant review committee memberships and editorial positions with front ranked gastrointestinal journals.
Dr Fedorak is the President of Canadian Digestive Health Foundation and Chairman, Research Committee, World Gastroenterology Organization. He is a member of the Active Medical Staff at both the University of Alberta Hospitals and the Cross Cancer Institute, and is a Consulting Physician at the Stollery Children’s Health Centre of Northern Alberta and the Royal Alexandra Hospital.Dr. Fedorak has served as President of the Canadian Association of Gastroenterology, President of the University of Alberta Hospital Medical Staff, President of the Alberta Society of Gastroenterology, President of the World Congress of Gastroenterology Bid Federation, General Secretary of the Pan American Congress of Gastroenterology and President of the World Congress of Gastroenterology. In 2008 Dr. Fedorak was appointed Fellow, Royal College of Physicians, London, and in 2009 Fellow, Canadian Academy of Health Sciences.

Dr. Sunita Vohra, MD, FRCPC, MSc
Director - CARE Program, PedCAM Network
Professor, Faculty of Medicine & Dentistry, University of Alberta

Dr. Vohra is a pediatrician and clinician scientist, with a Masters degree in clinical epidemiology and fellowship training in clinical pharmacology. A Professor in the Faculty of Medicine and School of Public Health at the University of Alberta, Dr. Vohra is the founding director of Canada's first academic pediatric integrative medicine program, the Complementary and Alternative Research and Education (CARE) program at the Stollery Children's Hospital (www.care.ualberta.ca). She is a recipient of the Dr, Roger's Prize for Excellence in CAM research and has recently been elected to the Canadian Academy of Health Sciences, considered one of the highest honours for individuals in the Canadian health sciences community   Dr. Vohra is recognized as an expert in complementary and alternative medicine (CAM) by Health Canada and has worked with the agency to identify and mitigate harms related to natural health product use. She was invited to write the Canadian Pediatric Society statement on the use of natural health products in children and was co-principal author of the American Academy of Pediatrics statement on the use of CAM in children.
Dr. Vohra is a member of the Executive Committee for the American Academy of Pediatrics’ Section on Complementary and Integrative Medicine. Dr. Vohra is the founding director of the Canadian Pediatric CAM Network (PedCAM) (www.pedcam.ca).

Back to management